32917219|t|Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-kappabeta pathway.
32917219|a|BACKGROUND: Chronic hyperammonemia induces neuroinflammation in cerebellum, with glial activation and enhanced activation of the TNFR1-NF-kB-glutaminase-glutamate-GABA pathway. Hyperammonemia also increases glycinergic neurotransmission. These alterations contribute to cognitive and motor impairment. Activation of glycine receptors is reduced by extracellular cGMP, which levels are reduced in cerebellum of hyperammonemic rats in vivo. We hypothesized that enhanced glycinergic neurotransmission in hyperammonemic rats (1) contributes to induce neuroinflammation and glutamatergic and GABAergic neurotransmission alterations; (2) is a consequence of the reduced extracellular cGMP levels. The aims were to assess, in cerebellum of hyperammonemic rats, (a) whether blocking glycine receptors with the antagonist strychnine reduces neuroinflammation; (b) the cellular localization of glycine receptor; (c) the effects of blocking glycine receptors on the TNFR1-NF-kB-glutaminase-glutamate-GABA pathway and microglia activation; (d) whether adding extracellular cGMP reproduces the effects of strychnine. METHODS: We analyzed in freshly isolated cerebellar slices from control or hyperammonemic rats the effects of strychnine on activation of microglia and astrocytes, the content of TNFa and IL1b, the surface expression of ADAM17, TNFR1 and transporters, the phosphorylation levels of ERK, p38 and ADAM17. The cellular localization of glycine receptor was assessed by immunofluorescence. We analyzed the content of TNFa, IL1b, HMGB1, glutaminase, and the level of TNF-a mRNA and NF-kappaB in Purkinje neurons. Extracellular concentrations of glutamate and GABA were performed by in vivo microdialysis in cerebellum. We tested whether extracellular cGMP reproduces the effects of strychnine in ex vivo cerebellar slices. RESULTS: Glycine receptors are expressed mainly in Purkinje cells. In hyperammonemic rats, enhanced glycinergic neurotransmission leads to reduced membrane expression of ADAM17, resulting in increased surface expression and activation of TNFR1 and of the associated NF-kB pathway. This increases the expression in Purkinje neurons of TNFa, IL-1b, HMGB1, and glutaminase. Increased glutaminase activity leads to increased extracellular glutamate, which increases extracellular GABA. Increased extracellular glutamate and HMGB1 potentiate microglial activation. Blocking glycine receptors with strychnine or extracellular cGMP completely prevents the above pathway in hyperammonemic rats. CONCLUSIONS: Glycinergic neurotransmission modulates neuroinflammation. Enhanced glycinergic neurotransmission in hyperammonemia would be due to reduced extracellular cGMP. These results shed some light on possible new therapeutic target pathways for pathologies associated to neuroinflammation.
32917219	35	52	neuroinflammation	Disease	MESH:D000090862
32917219	106	112	ADAM17	Gene	57027
32917219	113	118	TNFR1	Gene	25625
32917219	161	175	hyperammonemia	Disease	MESH:D022124
32917219	184	201	neuroinflammation	Disease	MESH:D000090862
32917219	270	275	TNFR1	Gene	25625
32917219	276	281	NF-kB	Gene	309165
32917219	282	293	glutaminase	Gene	24398
32917219	294	303	glutamate	Chemical	MESH:D018698
32917219	304	308	GABA	Chemical	MESH:D005680
32917219	318	332	Hyperammonemia	Disease	MESH:D022124
32917219	411	441	cognitive and motor impairment	Disease	MESH:D003072
32917219	503	507	cGMP	Chemical	MESH:D006152
32917219	551	565	hyperammonemic	Disease	
32917219	566	570	rats	Species	10116
32917219	643	657	hyperammonemic	Disease	
32917219	658	662	rats	Species	10116
32917219	689	706	neuroinflammation	Disease	MESH:D000090862
32917219	820	824	cGMP	Chemical	MESH:D006152
32917219	875	889	hyperammonemic	Disease	
32917219	890	894	rats	Species	10116
32917219	955	965	strychnine	Chemical	MESH:D013331
32917219	974	991	neuroinflammation	Disease	MESH:D000090862
32917219	1097	1102	TNFR1	Gene	25625
32917219	1103	1108	NF-kB	Gene	309165
32917219	1109	1120	glutaminase	Gene	24398
32917219	1121	1130	glutamate	Chemical	MESH:D018698
32917219	1131	1135	GABA	Chemical	MESH:D005680
32917219	1203	1207	cGMP	Chemical	MESH:D006152
32917219	1234	1244	strychnine	Chemical	MESH:D013331
32917219	1321	1335	hyperammonemic	Disease	
32917219	1336	1340	rats	Species	10116
32917219	1356	1366	strychnine	Chemical	MESH:D013331
32917219	1425	1429	TNFa	Gene	24835
32917219	1434	1438	IL1b	Gene	24494
32917219	1466	1472	ADAM17	Gene	57027
32917219	1474	1479	TNFR1	Gene	25625
32917219	1528	1531	ERK	Gene	24338
32917219	1533	1536	p38	Gene	81649
32917219	1541	1547	ADAM17	Gene	57027
32917219	1658	1662	TNFa	Gene	24835
32917219	1664	1668	IL1b	Gene	24494
32917219	1670	1675	HMGB1	Gene	25459
32917219	1677	1688	glutaminase	Gene	24398
32917219	1707	1712	TNF-a	Gene	24835
32917219	1785	1794	glutamate	Chemical	MESH:D018698
32917219	1799	1803	GABA	Chemical	MESH:D005680
32917219	1891	1895	cGMP	Chemical	MESH:D006152
32917219	1922	1932	strychnine	Chemical	MESH:D013331
32917219	2033	2047	hyperammonemic	Disease	
32917219	2048	2052	rats	Species	10116
32917219	2133	2139	ADAM17	Gene	57027
32917219	2201	2206	TNFR1	Gene	25625
32917219	2229	2234	NF-kB	Gene	309165
32917219	2297	2301	TNFa	Gene	24835
32917219	2303	2308	IL-1b	Gene	24494
32917219	2310	2315	HMGB1	Gene	25459
32917219	2321	2332	glutaminase	Gene	24398
32917219	2344	2355	glutaminase	Gene	24398
32917219	2398	2407	glutamate	Chemical	MESH:D018698
32917219	2439	2443	GABA	Chemical	MESH:D005680
32917219	2469	2478	glutamate	Chemical	MESH:D018698
32917219	2483	2488	HMGB1	Gene	25459
32917219	2555	2565	strychnine	Chemical	MESH:D013331
32917219	2583	2587	cGMP	Chemical	MESH:D006152
32917219	2629	2643	hyperammonemic	Disease	
32917219	2644	2648	rats	Species	10116
32917219	2703	2720	neuroinflammation	Disease	MESH:D000090862
32917219	2764	2778	hyperammonemia	Disease	MESH:D022124
32917219	2817	2821	cGMP	Chemical	MESH:D006152
32917219	2927	2944	neuroinflammation	Disease	MESH:D000090862
32917219	Association	MESH:D018698	24398
32917219	Association	MESH:D005680	24398
32917219	Association	25625	309165
32917219	Association	MESH:D005680	MESH:D022124
32917219	Positive_Correlation	MESH:D022124	25625
32917219	Association	MESH:D018698	309165
32917219	Association	MESH:D022124	24398
32917219	Association	MESH:D018698	MESH:D022124
32917219	Association	309165	57027
32917219	Positive_Correlation	MESH:D022124	309165

